Search research articles
Contact Us
Filters
Showing results (721-730 of 1,352) with videos related to
Page
of 136
Sort By:
Schizophrenia Bulletin
|
September 17, 2005
Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia
Raymond Y Cho, Judith M Ford, John H Krystal, et al.
Plos Computational Biology
|
April 26, 2024
Spatial transcriptome-guided multi-scale framework connects P. aeruginosa metabolic states to oxidative stress biofilm microenvironment
Tracy J Kuper, Mohammad Mazharul Islam, Shayn M Peirce-Cottler, et al.
The American Journal of Psychiatry
|
November 3, 2001
Cortical responsiveness during inner speech in schizophrenia: an event-related potential study
J M Ford, D H Mathalon, S Kalba, et al.
The American Journal of Psychiatry
|
December 1, 2001
Neurophysiological evidence of corollary discharge dysfunction in schizophrenia
J M Ford, D H Mathalon, T Heinks, et al.
Biological Psychiatry
|
October 16, 2001
Cortical responsiveness during talking and listening in schizophrenia: an event-related brain potential study
J M Ford, D H Mathalon, S Kalba, et al.
Brain Connectivity
|
November 30, 2016
Abnormal Coupling Between Default Mode Network and Delta and Beta Band Brain Electric Activity in Psychotic Patients
Anja Baenninger, Vanessa A Palzes, Brian J Roach, et al.
Molecular Cell
|
May 23, 2006
A kinase-independent function of c-Abl in promoting proteolytic destruction of damaged DNA binding proteins
Xiaoai Chen, Jianxuan Zhang, Jennifer Lee, et al.
Pediatric Blood & Cancer
|
July 4, 2018
Origins of STIL-TAL1 fusion genes in children who later developed paediatric T-cell acute lymphoblastic leukaemia: An investigation of neonatal blood spots
Britt M Gustafsson, Kristin Mattsson, Gordana Bogdanovic, et al.
Diseases (Basel, Switzerland)
|
September 26, 2025
Emerging Clinical Role of Tavapadon, a Novel Dopamine Partial Agonist, in the Treatment of Parkinson's Disease
Alan D Kaye, Bennett M Ford, Brennan M Abbott, et al.
Molecular Pharmacology
|
May 9, 1998
Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B
Z Nie, Y Mei, M Ford, et al.
Page
of 136
Search research articles
Search
Showing results (721-730 of 1,352) with videos related to
Sort By:
Page
of 136
Schizophrenia Bulletin
|
September 17, 2005
Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia
Raymond Y Cho, Judith M Ford, John H Krystal, et al.
Plos Computational Biology
|
April 26, 2024
Spatial transcriptome-guided multi-scale framework connects P. aeruginosa metabolic states to oxidative stress biofilm microenvironment
Tracy J Kuper, Mohammad Mazharul Islam, Shayn M Peirce-Cottler, et al.
The American Journal of Psychiatry
|
November 3, 2001
Cortical responsiveness during inner speech in schizophrenia: an event-related potential study
J M Ford, D H Mathalon, S Kalba, et al.
The American Journal of Psychiatry
|
December 1, 2001
Neurophysiological evidence of corollary discharge dysfunction in schizophrenia
J M Ford, D H Mathalon, T Heinks, et al.
Biological Psychiatry
|
October 16, 2001
Cortical responsiveness during talking and listening in schizophrenia: an event-related brain potential study
J M Ford, D H Mathalon, S Kalba, et al.
Brain Connectivity
|
November 30, 2016
Abnormal Coupling Between Default Mode Network and Delta and Beta Band Brain Electric Activity in Psychotic Patients
Anja Baenninger, Vanessa A Palzes, Brian J Roach, et al.
Molecular Cell
|
May 23, 2006
A kinase-independent function of c-Abl in promoting proteolytic destruction of damaged DNA binding proteins
Xiaoai Chen, Jianxuan Zhang, Jennifer Lee, et al.
Pediatric Blood & Cancer
|
July 4, 2018
Origins of STIL-TAL1 fusion genes in children who later developed paediatric T-cell acute lymphoblastic leukaemia: An investigation of neonatal blood spots
Britt M Gustafsson, Kristin Mattsson, Gordana Bogdanovic, et al.
Diseases (Basel, Switzerland)
|
September 26, 2025
Emerging Clinical Role of Tavapadon, a Novel Dopamine Partial Agonist, in the Treatment of Parkinson's Disease
Alan D Kaye, Bennett M Ford, Brennan M Abbott, et al.
Molecular Pharmacology
|
May 9, 1998
Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B
Z Nie, Y Mei, M Ford, et al.
Page
of 136